SG11202112008PA - Chromophore-labeled oligosaccharide markers and methods of use thereof - Google Patents
Chromophore-labeled oligosaccharide markers and methods of use thereofInfo
- Publication number
- SG11202112008PA SG11202112008PA SG11202112008PA SG11202112008PA SG11202112008PA SG 11202112008P A SG11202112008P A SG 11202112008PA SG 11202112008P A SG11202112008P A SG 11202112008PA SG 11202112008P A SG11202112008P A SG 11202112008PA SG 11202112008P A SG11202112008P A SG 11202112008PA
- Authority
- SG
- Singapore
- Prior art keywords
- chromophore
- methods
- labeled oligosaccharide
- oligosaccharide markers
- markers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5097—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving plant cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4055—Concentrating samples by solubility techniques
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962847912P | 2019-05-14 | 2019-05-14 | |
| US201962871205P | 2019-07-08 | 2019-07-08 | |
| US16/871,188 US11474100B2 (en) | 2019-05-14 | 2020-05-11 | Chromophore-labeled oligosaccharide markers and methods of use thereof |
| PCT/CN2020/089893 WO2020228708A1 (en) | 2019-05-14 | 2020-05-13 | Chromophore-labeled oligosaccharide markers and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202112008PA true SG11202112008PA (en) | 2021-11-29 |
Family
ID=73228064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202112008PA SG11202112008PA (en) | 2019-05-14 | 2020-05-13 | Chromophore-labeled oligosaccharide markers and methods of use thereof |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11474100B2 (en) |
| CN (1) | CN113950623B (en) |
| SG (1) | SG11202112008PA (en) |
| WO (1) | WO2020228708A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113004432B (en) * | 2021-03-05 | 2022-02-25 | 中国科学院昆明植物研究所 | Dendrobium officinale oligosaccharide, dendrobium officinale oligosaccharide derivative and preparation method and application thereof |
| CN113109489B (en) * | 2021-05-21 | 2023-05-23 | 夏永刚 | Analysis method of traditional Chinese medicine polysaccharide aldose, ketose, sugar alcohol, uronic acid and amino sugar |
| CN114235781A (en) * | 2021-12-22 | 2022-03-25 | 上海海洋大学 | Method for quantitatively detecting beta-galactosidase in seawater based on surface enhanced Raman spectroscopy technology |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1920774A4 (en) * | 2005-07-29 | 2008-09-24 | Suntory Ltd | Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material |
| WO2007111321A1 (en) * | 2006-03-26 | 2007-10-04 | Japan Science And Technology Agency | Method of analyzing sulfated polysaccharide or sulfated oligosaccharide, pharmaceutical composition and drug containing sulfated polysaccharide or sulfated oligosaccharide, method of producing the pharmaceutical composition and the drug and method of treating, diagnosing, symptom-relieving and preventing disease |
| AU2008298611A1 (en) * | 2007-09-14 | 2009-03-19 | Albert Y. Leung | System and method for assessing traditional medicines |
| CN101539550B (en) * | 2009-04-28 | 2012-05-23 | 李绍平 | Qualitative and quantitative analysis method for polyoses |
| CN102749299A (en) * | 2012-07-13 | 2012-10-24 | 山东阿如拉药物研究开发有限公司 | Quality detection method of traditional Chinese medicine composition medlar thirst quenching preparation |
| CN103884789B (en) * | 2014-03-21 | 2015-04-29 | 福建农林大学 | Method for rapidly determining polysaccharide peptide in lucid ganoderma product |
| CN105675779B (en) * | 2016-01-15 | 2017-07-21 | 大连工业大学 | A kind of method of quantitative detection acid polysaccharide containing alditol |
| CN106831896A (en) * | 2016-12-26 | 2017-06-13 | 大连工业大学 | Disaccharides containing uronic acid is based on the analysis method and preparation method of reduction amine derivative |
| CN106770871B (en) * | 2016-12-26 | 2019-04-12 | 大连工业大学 | A kind of method of quantitative detection acid polysaccharide containing alditol |
-
2020
- 2020-05-11 US US16/871,188 patent/US11474100B2/en active Active
- 2020-05-13 WO PCT/CN2020/089893 patent/WO2020228708A1/en active Application Filing
- 2020-05-13 SG SG11202112008PA patent/SG11202112008PA/en unknown
- 2020-05-13 CN CN202080035867.4A patent/CN113950623B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11474100B2 (en) | 2022-10-18 |
| CN113950623B (en) | 2024-03-19 |
| WO2020228708A1 (en) | 2020-11-19 |
| CN113950623A (en) | 2022-01-18 |
| US20200363404A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3700527A4 (en) | Papd5 inhibitors and methods of use thereof | |
| IL279475A (en) | Ectonucleotidase inhibitors and methods of use thereof | |
| IL287751A (en) | Kcnt1 inhibitors and methods of use | |
| IL287768A (en) | Kcnt1 inhibitors and methods of use | |
| IL276711A (en) | Arginase inhibitors and methods of use thereof | |
| IL287973A (en) | Acss2 inhibitors and methods of use thereof | |
| IL278989A (en) | Masp-2 inhibitors and methods of use | |
| EP3572400C0 (en) | Ezh2 inhibitor and use thereof | |
| IL274504A (en) | Acss2 inhibitors and methods of use thereof | |
| EP3735242A4 (en) | Metallo-beta-lactamase inhibitors and methods of use thereof | |
| SG11202112008PA (en) | Chromophore-labeled oligosaccharide markers and methods of use thereof | |
| ZA202100780B (en) | Bismuth-thiol compositions and methods of use | |
| IL276135A (en) | Compositions and methods of use | |
| EP3846808A4 (en) | Papd5 inhibitors and methods of use thereof | |
| IL282350A (en) | Rgmc-selective inhibitors and use thereof | |
| IL286481A (en) | Pyridazinones and methods of use thereof | |
| SG11202100533VA (en) | Hepato-biliary-pancreatic tissues and methods of making same | |
| IL283782A (en) | Anellosomes and methods of use | |
| IL291730A (en) | Protein-macromolecule conjugates and methods of use thereof | |
| IL286149A (en) | Caspase inhibitors and methods of use thereof | |
| IL282533A (en) | Oligosaccharide compositions and methods of use thereof | |
| IL276053A (en) | Therapeutic-gard and method of use thereof | |
| EP3793552C0 (en) | Abhd12 inhibitors and methods of making and using same | |
| IL289127A (en) | Ppm1a inhibitors and methods of using same | |
| GB2589398B (en) | Compounds and methods of use |